Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 67.50
+1.00 (1.50%)
At close: Mar 24, 2026
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 304 million as of March 25, 2026. Its market cap has increased by 114.59% in one year.
Market Cap
304.00M
Enterprise Value
311.75M
Revenue
113.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
67.50
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 304.00M, an increase of 711.53%. That is a compound annual growth rate of 11.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 304.00M | 20.93% |
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.70B |
| Oxford Nanopore Technologies | 1.12B |
| Oxford Biomedica | 727.66M |
| PureTech Health | 277.10M |
| Scancell Holdings | 119.34M |
| 4basebio | 80.48M |
| Bioventix | 73.67M |
| Hemogenyx Pharmaceuticals | 62.83M |